pRxEngage
pRxEngage is an Atlanta-based SaaS company that operates a Clinical Trial Discovery Hub embedded on partner websites, enabling cancer patients and families to search trials by condition and location using plain-language decision support, with a stated focus on underserved communities.
- Company typePrivate
- Founded2025
- HeadquartersAtlanta, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What pRxEngage does
pRxEngage Inc. is a private, Atlanta-based SaaS company founded in 2025 that operates in the clinical trial patient-engagement segment. Its sole product, the Clinical Trial Discovery Hub, enables cancer patients and their families to search for clinical trials by condition and location and to access plain-language information intended to support informed decisions about trial participation. The company explicitly targets visibility and access barriers for underserved communities, with initial emphasis on cancers such as prostate cancer and Acute Myeloid Leukemia.
The platform is delivered through an embedded/white-label distribution model: rather than operating a standalone consumer site, pRxEngage integrates its discovery hub directly into partner organization websites. Its first disclosed partner is Hive Cancer Support, with the partnership announced on World Cancer Day (February 4, 2026). This channel strategy is the company's primary go-to-market mechanism and the basis for its claimed distribution advantage. The company markets itself as "AI-powered," but no underlying AI/ML architecture, proprietary models, or data assets are disclosed in available sources. The technology stack, APIs, and SDK details are not documented.
The business model is opaque in the provided data: pricing is not publicly disclosed, revenue figures are unavailable, and the company completed one funding round in July 2025 with $0 in disclosed capital and unknown investors. Customer segmentation is described as a single vertical (cancer patients and families) served as a persona rather than a paying segment; the implied monetizable customer is the B2B partner (advocacy organizations, and presumably trial sponsors or CROs downstream), but no contracts or pricing tiers are disclosed. Leadership consists of three individuals — Founder & CEO Keith Berelowitz, CTO Charlie Myrick, and Head of Product Ethan Graff-Radford — consistent with an early-stage team of 1–10 employees.
pRxEngage firmographics
Firmographics- Name
- pRxEngage
- Legal name
- pRxEngage Inc.
- Website
- https://prxengage.com
- Company type
- Private
- Founded year
- 2025
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- pRxEngage is an Atlanta-based SaaS company that operates a Clinical Trial Discovery Hub embedded on partner websites, enabling cancer patients and families to search trials by condition and location using plain-language decision support, with a stated focus on underserved communities.
- Ownership category
- akta.pro rank
pRxEngage industry classification
Industry- Product category
- Clinical Trial Recruitment Software
- NAICS
- Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials) (HLAAANAI)
- akta.pro secondary industry
- Site & Investigator Platforms (Site Payments, Feasibility, Activation) (HLACAOAJ)
Keywords
Where pRxEngage is headquartered
LocationHeadquarters
- HQ city
- Atlanta
- HQ country
- United States
- HQ region
- North America
Markets served
pRxEngage business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Distribution channels1 record
pRxEngage product offering
Product offeringCore offering
pRxEngage sells an AI-powered SaaS Clinical Trial Discovery Hub that allows patients (primarily cancer patients and their families) to search for clinical trials by condition and location and access plain language information to support informed decisions about participation. The hub is embedded on partner organization websites, enabling cancer support groups to offer clinical trial discovery directly to their audiences, with explicit focus on reducing information gaps for underserved communities and specific cancers such as prostate cancer and Acute Myeloid Leukemia.
Product overview
pRxEngage offers a single unified product: the Clinical Trial Discovery Hub. This hub is embedded on partner websites (such as Hive Cancer Support) to make clinical trial information more accessible to patients and their families. The platform enables search functionality by condition and location and provides plain language information to support decision-making, addressing visibility and access barriers particularly for underserved communities.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Trial Discovery Hub An AI-powered SaaS clinical trial discovery platform that enables visitors to search clinical trials by condition and location and provides plain language information to support informed decision-making about trial participation; designed to be embedded on partner organization websites (e.g., cancer support organizations) to expand reach to patient audiences, particularly underserved communities.
Companies that use pRxEngage
Customer profileSegments1 record
Ideal customer profiles2 records
pRxEngage technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
pRxEngage partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Hive Cancer SupportcorepRxEngage's clinical trial discovery hub is embedded on Hive Cancer Support's website, making clinical trial information more accessible to cancer patients and their families. The hub enables visitors to search trials by condition and location and provides plain language information to support decision-making. The partnership specifically aims to reduce information gaps for cancers such as prostate cancer and Acute Myeloid Leukemia.
Recent moves4 records
Expansion highlights5 records
pRxEngage competitors and assessment
Company assessmentDirect peers
- Massive Bio: AI-powered clinical trial matching platform focused on cancer patients; provides a directly comparable patient-facing discovery and pre-screening workflow that competes with pRxEngage's discovery hub.
- Antidote (formerly TrialReach): Patient-facing clinical trial search and matching platform serving condition-specific audiences; directly comparable to pRxEngage's patient discovery and decision-support functionality.
- Deep 6 AI: AI-driven clinical trial matching that pulls from EHR data to surface eligible patients for sponsors; comparable as an AI-enabled clinical trial enablement platform targeting trial recruitment.
- Mendel (Mendel.ai): AI clinical trial matching platform that uses NLP over medical records to match patients to oncology and other trials; competes in the same AI-powered trial enablement category.
- Power (patient recruitment): Patient-facing trial discovery and recruitment platform with similar condition-and-location search and plain-language positioning aimed at accelerating enrollment.
- CureMatch: Precision-medicine oncology decision support that overlaps with pRxEngage's cancer-specific trial discovery and plain-language patient enablement mission.
Broad incumbents
- IQVIA (Patient & Site Solutions): Large CRO offering end-to-end clinical trial recruitment, site activation, and patient engagement services; competes with pRxEngage as a broad incumbent with overlapping patient-discovery and engagement capabilities.
- ClinicalTrials.gov (NIH/NLM): Government-run free clinical trial registry providing condition-and-location search; sets the baseline patient-facing discovery experience that any commercial entrant like pRxEngage must demonstrably outperform.
Regional players
- American Cancer Society (Clinical Trial Matching): Operates a US-focused cancer patient clinical trial matching service embedded on the ACS site; closely parallels pRxEngage's embedded/white-label model with cancer advocacy organizations.
Others
- Be the Match / NMDP (clinical trials support): Patient advocacy organization connecting blood cancer (including AML) patients to treatment and trial opportunities; relevant as a comparable cancer-advocacy distribution channel that pRxEngage's embedded model could either partner with or compete against.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
pRxEngage social profiles
Digital presencepRxEngage financial estimates
Financial estimateRevenue estimate
Valuation estimate
pRxEngage leadership team
Management profileNumber of profiles
Profiles3 records
pRxEngage funding detail
Funding detailFunding overview
Funding rounds2 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
pRxEngage M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about pRxEngage
What does pRxEngage do?
pRxEngage sells an AI-powered SaaS Clinical Trial Discovery Hub that allows patients (primarily cancer patients and their families) to search for clinical trials by condition and location and access plain language information to support informed decisions about participation. The hub is embedded on partner organization websites, enabling cancer support groups to offer clinical trial discovery directly to their audiences, with explicit focus on reducing information gaps for underserved communities and specific cancers such as prostate cancer and Acute Myeloid Leukemia.
Is pRxEngage a public or private company?
pRxEngage is a private company. It is classified as unknown and is currently operating.
When was pRxEngage founded?
pRxEngage was founded in 2025. It employs 11 to 50 people.
Where is pRxEngage based?
pRxEngage is headquartered in Atlanta, United States, in the North America region.
Who are pRxEngage's main competitors?
Direct peers on record are Massive Bio, Antidote (formerly TrialReach), Deep 6 AI, Mendel (Mendel.ai), Power (patient recruitment) and CureMatch. Broad incumbents are IQVIA (Patient & Site Solutions) and ClinicalTrials.gov (NIH/NLM). American Cancer Society (Clinical Trial Matching) is listed as a regional player. Be the Match / NMDP (clinical trials support) is listed as an others.
Does pRxEngage have an API?
No public API is recorded for pRxEngage.
What industry is pRxEngage in?
pRxEngage's product category is Clinical Trial Recruitment Software. Its primary akta.pro industry code is HLAAANAI, Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials), with a secondary code of HLACAOAJ, Site & Investigator Platforms (Site Payments, Feasibility, Activation). Its NAICS code is 5132 and its SIC code is 7372.